Increased Expression of Inflammatory Cytokines and Discogenic Neck Pain

Xinjian Kang, Man Qian, Tao Qin, Mingli Liu, Haiwei Xu, Baoshan Xu

Orthopaedic Surgery ›› 2024, Vol. 16 ›› Issue (1) : 227-233.

PDF
Orthopaedic Surgery ›› 2024, Vol. 16 ›› Issue (1) : 227-233. DOI: 10.1111/os.13963
RESEARCH ARTICLE

Increased Expression of Inflammatory Cytokines and Discogenic Neck Pain

Author information +
History +

Abstract

Objective:: Although neck pain has become a serious economic and social problem worldwide, the etiology remains poorly understood. The aim of current study is to explore the possible pathogenesis of discogenic neck pain by analyzing the relationship between inflammatory cytokines and discogenic neck pain and provide a valuable reference for the prevention and treatment of discogenic neck pain.

Methods:: A total of 111 cervical disc samples were collected between October 1, 2021, and October 1, 2022: 38 samples from the discogenic neck pain group, 41 samples from the symptomatic control group, and 32 samples from the normal control group. The concentration of nitric oxide (NO), interleukin (IL)-1, interleukin (IL)-6, and tumor necrosis factor alpha (TNF-α) was determined using the enzyme-linked immunosorbent assay in each sample, and the degeneration degree of the target discs were evaluated using T2-weighted sagittal magnetic resonance imaging (MRI) according to the Miyazaki disc degeneration grading system. Whether the differences among the three groups were statistically significant was tested using one-way analysis of variance and an unpaired t-test, respectively.

Results:: The differences of the baseline characteristics were not statistically significant between the discogenic neck pain group and the symptomatic control group (p > 0.05). The expression of inflammatory cytokines in disc samples from the discogenic neck pain group (NO: 9.89 ± 1.75, IL-1β: 10.74 ± 1.92, IL-6:31.65 ± 2.46, and TNF-α: 5.96 ± 1.91) was increased in comparison with the disc samples from both the symptomatic control group (NO: 7.15 ± 2.78, IL-1β: 8.03 ± 1.87, IL-6: 25.79 ± 2.12, and TNF-α: 4.18 ± 2.87) and the normal control group (NO: 6.11 ± 1.37, IL-1β: 5.84 ± 2.25, IL-6: 20.65 ± 1.26, and TNF-α: 2.05 ± 0.58). The differences were statistically significant (p < 0.001). Further, there were no statistical differences in the degree of degeneration between discogenic neck pain group and symptomatic control group.

Conclusions:: The increased expression of inflammatory cytokines in diseased cervical intervertebral discs might play a key role in the pathogenesis of discogenic neck pain. Although inflammation is involved in intervertebral disc degeneration, there is no linear positive correlation between the concentration of inflammatory cytokines and the degree of disc degeneration.

Keywords

cytokines / intervertebral disc degeneration / low back pain / neck pain / pathogenesis

Cite this article

Download citation ▾
Xinjian Kang, Man Qian, Tao Qin, Mingli Liu, Haiwei Xu, Baoshan Xu. Increased Expression of Inflammatory Cytokines and Discogenic Neck Pain. Orthopaedic Surgery, 2024, 16(1): 227‒233 https://doi.org/10.1111/os.13963

References

[1]
Fejer R, Kyvik KO, Hartvigsen J. The prevalence of neck pain in the world population: a systematic critical review of the literature. Eur Spine J. 2006;15:834–848.
[2]
Manchikanti L, Boswell MV, Singh V, et al. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Phys. 2009;12:699–802.
[3]
Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. Cervical epidural injections in chronic discogenic neck pain without disc herniation or radiculitis: preliminary results of a randomized, double-blind, controlled trial. Pain Phys. 2010;13:E265–E278.
[4]
Peng B, Depalma MJ. Cervical disc degeneration and neck pain. J Pain Res. 2018;11:2853–2857.
[5]
Onyewu O, Manchikanti L, Falco FJ, et al. An update of the appraisal of the accuracy and utility of cervical discography in chronic neck pain. Pain Phys. 2012;15:E777–E806.
[6]
Lotz JC, Ulrich JA. Innervation, inflammation, and hypermobility may characterize pathologic disc degeneration: review of animal model data. J Bone Joint Surg Am. 2006;88:76–82.
[7]
Cohen SP, Hooten WM. Advances in the diagnosis and management of neck pain. BMJ. 2017;358:j3221.
[8]
He L, Ni J, Wu B, Yue J, Cao G, Guo Y, et al. Coblation annuloplasty in cervical discogenic pain without radiculopathy. Wideochir Inne Tech Maloinwazyjne. 2020;15(2):305–312.
[9]
Fujimoto K, Miyagi M, Ishikawa T, Inoue G, Eguchi Y, Kamoda H, et al. Sensory and autonomic innervation of the cervical intervertebral disc in rats: the pathomechanics of chronic discogenic neck pain. Spine. 2012;37:1357–1362.
[10]
Bogduk N, Windsor M, Inglis A. The innervation of the cervical interve- r tebral discs. Spine. 1988;13:2–8.
[11]
Yang L, Yang C, Pang X, Li D, Yang H, Zhang X, et al. Mechanoreceptors in diseased cervical intervertebral disc and vertigo. Spine. 2017;42:540–546.
[12]
Mendel T, Wink CS, Zimny ML. Neural elements in human cervical intervertebral discs. Spine. 1992;17:132–135.
[13]
Connor PM, Darden BV. Cervical discography complications and clinical efficacy. Spine. 1993;18:2035–2038.
[14]
Wu B, Yang L, Peng B. Ingrowth of nociceptive receptors into diseased cervical intervertebral disc is associated with discogenic neck pain. Pain Med. 2019;20:1072–1077.
[15]
Watanabe T, Sakai D, Yamamoto Y, Iwashina T, Serigano K, Tamura F, et al. Human nucleus pulposus cells significantly enhanced biological properties in a coculture system with direct cell-to-cell contact with autologous mesenchymal stem cells. J Orthop Res. 2010;28:623–630.
[16]
Ao X, Li Y, Jiang T, Li C, Lian Z, Wang L, et al. Angiopoietin-2 promotes mechanical stress-induced extracellular matrix degradation in annulus Fibrosus via the HIF-1α/NF-κB signaling pathway. Orthop Surg. 2023;15(9):2410–2422.
[17]
Liu T, Liu Y, Peng B. Cervical intervertebral disc degeneration and dizziness. World J Clin Cases. 2021;9(9):2146–2152.
[18]
Xin J, Wang Y, Zheng Z, Wang S, Na S, Zhang S. Treatment of intervertebral disc degeneration. Orthop Surg. 2022;14(7):1271–1280.
[19]
Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10:44–56.
[20]
Lee SW, Han HC. Methylene blue application to lessen pain: its analgesic effect and mechanism. Front Neurosci. 2021;15:663650.
[21]
Roth DA. Cervical analgesic discography. A new test for the definitive diagnosis of the painful-disk syndrome. JAMA. 1976;235:1713–1714.
[22]
Miyazaki M, Hong SW, Yoon SH, Zou J, Tow B, Alanay A, et al. Kinematic analysis of the relationship between the grade of disc degeneration and motion unit of the cervical spine. Spine. 2008;33:187–193.
[23]
Aripaka SS, Bech-Azeddine R, Jørgensen LM, Chughtai SA, Gaarde C, Bendix T, et al. Low back pain scores correlate with the cytokine mRNA level in lumbar disc biopsies: a study of inflammatory markers in patients undergoing lumbar spinal fusion. Eur Spine J. 2021;30:2967–2974.
[24]
Li H, Tian L, Li J, et al. The roles of circRNAs in intervertebral disc degeneration: inflammation, extracellular matrix metabolism, and apoptosis. Anal Cell Pathol (Amst). 2022;2022:9550499.
[25]
Jacobsen HE, Khan AN, Levine ME, Filippi CG, Chahine NO. Severity of intervertebral disc herniation regulates cytokine and chemokine levels in patients with chronic radicular back pain. Osteoarthr Cartil. 2020;28:1341–1350.
[26]
Navone SE, Marfia G, Giannoni A, Beretta M, Guarnaccia L, Gualtierotti R, et al. Inflammatory mediators and signal pathways controlling intervertebral disc degeneration. Histol Histopathol. 2017;32:523–542.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF

Accesses

Citations

Detail

Sections
Recommended

/